论文部分内容阅读
目的:探讨哌拉西林舒巴坦对急性细菌性呼吸道感染的临床疗效。方法:选择病例采用随机分组方法,用哌拉西林舒巴坦对急性细菌性呼吸道感染进行疗效观察。结果:对照组中痊愈率为60.00%,显效率为80.00%,有效率为96.67%,细菌清除率为95.65%;观察组痊愈率为83.33%,显效率为96.67%,有效率为100.00%,细菌清除率为96.67%。观察组与对照组的痊愈率相比,差异具有统计学意义(P<0.05),两组显效率、有效率与细菌清除率相比,差异无统计学意义,P>0.05。结论:哌拉西林舒巴坦对于急性细菌性呼吸道感染具有良好的效果,是一种杀菌作用强的耐酶抗生素。
Objective: To investigate the clinical efficacy of piperacillin-sulbactam in acute bacterial respiratory tract infection. Methods: The cases were randomly divided into groups and treated with piperacillin and sulbactam for the treatment of acute bacterial respiratory tract infection. Results: The cure rate in the control group was 60.00%, the effective rate was 80.00%, the effective rate was 96.67% and the bacterial clearance rate was 95.65%. The cure rate in the observation group was 83.33%, the effective rate was 96.67% and the effective rate was 100.00% Bacterial clearance rate was 96.67%. The difference between the observation group and the control group was statistically significant (P <0.05). There was no significant difference between the two groups in the effective rate and the bacterial clearance rate (P> 0.05). Conclusion: Piperacillin-sulbactam has a good effect on acute bacterial respiratory tract infection and is a bactericidal enzyme-resistant antibiotic.